Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Ready, Rebecca E.
and
Paulsen, Jane S.
2003.
Neuropsychological studies in geriatric psychiatry.
Current Opinion in Psychiatry,
Vol. 16,
Issue. 6,
p.
643.
2003.
Current Awareness in Geriatric Psychiatry.
International Journal of Geriatric Psychiatry,
Vol. 18,
Issue. 3,
p.
267.
Dedeoglu, Alpaslan
Choi, Ji-Kyung
Cormier, Kerry
Kowall, Neil W
and
Jenkins, Bruce G
2004.
Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile.
Brain Research,
Vol. 1012,
Issue. 1-2,
p.
60.
Kantarci, Kejal
and
Jack, Clifford R.
2004.
Quantitative magnetic resonance techniques as surrogate markers of Alzheimer’s disease.
NeuroRX,
Vol. 1,
Issue. 2,
p.
196.
Kantarci, Kejal
and
Jack, Clifford R.
2004.
Quantitative magnetic resonance techniques as surrogate markers of Alzheimer’s disease.
NeuroRX,
Vol. 1,
Issue. 2,
p.
196.
Camicioli, R.M
Korzan, J.R
Foster, S.L
Fisher, N.J
Emery, D.J
Bastos, A.C
and
Hanstock, C.C
2004.
Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia.
Neuroscience Letters,
Vol. 354,
Issue. 3,
p.
177.
Golomb, James
Kluger, Alan
and
Ferris, Steven H
2004.
Mild cognitive impairment: historical development and summary of research.
Dialogues in Clinical Neuroscience,
Vol. 6,
Issue. 4,
p.
351.
Martínez‐Bisbal, M. C.
Arana, E.
Martí‐Bonmatí, L.
Mollá, E.
and
Celda, B.
2004.
Cognitive impairment: classification by 1H magnetic resonance spectroscopy.
European Journal of Neurology,
Vol. 11,
Issue. 3,
p.
187.
Jones, Randall S.
and
Waldman, Adam D.
2004.
1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
Neurological Research,
Vol. 26,
Issue. 5,
p.
488.
Rudin, Markus
Beckmann, Nicolau
and
Rausch, Martin
2004.
Imaging in Biological Research, Part A.
Vol. 385,
Issue. ,
p.
240.
Kantarci, Kejal
2005.
Magnetic resonance markers for early diagnosis and progression of Alzheimer’s disease.
Expert Review of Neurotherapeutics,
Vol. 5,
Issue. 5,
p.
663.
Dickerson, Bradford C.
and
Sperling, Reisa A.
2005.
Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer’s disease.
NeuroRX,
Vol. 2,
Issue. 2,
p.
348.
Ackl, Nibal
Ising, Marcus
Schreiber, Yvonne A.
Atiya, Monika
Sonntag, Annette
and
Auer, Dorothee P.
2005.
Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
Neuroscience Letters,
Vol. 384,
Issue. 1-2,
p.
23.
Kantarci, Kejal
and
Jack, Clifford R.
2005.
Bioimaging in Neurodegeneration.
p.
95.
Dickerson, Bradford C.
and
Sperling, Reisa A.
2005.
Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer’s disease.
NeuroRX,
Vol. 2,
Issue. 2,
p.
348.
Martínez-Bisbal, M.C.
Arana, E.
Martí-Bonmatí, L.
Martínez-Granados, B.
and
Celda, B.
2006.
Deterioro cognitivo: clasificación mediante espectroscopia de resonancia magnética de protón y contribución de la imagen convencional.
Radiología,
Vol. 48,
Issue. 5,
p.
301.
Luccichenti, G.
Péran, P.
Cherubini, A.
Giugni, E.
Scarabino, T.
Hagberg, G. E.
and
Sabatini, U.
2006.
High Field Brain MRI.
p.
201.
Rosen, Yael
and
Lenkinski, Robert E.
2007.
Recent Advances in Magnetic Resonance Neurospectroscopy.
Neurotherapeutics,
Vol. 4,
Issue. 3,
p.
330.
Kantarci, Kejal
Weigand, Stephen D.
Petersen, Ronald C.
Boeve, Bradley F.
Knopman, David S.
Gunter, Jeffrey
Reyes, Denise
Shiung, Maria
O’Brien, Peter C.
Smith, Glenn E.
Ivnik, Robert J.
Tangalos, Eric G.
and
Jack, Clifford R.
2007.
Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease.
Neurobiology of Aging,
Vol. 28,
Issue. 9,
p.
1330.
Griffith, H. Randall
Okonkwo, Ozioma C.
den Hollander, Jan A.
Belue, Katherine
Lanza, Sara
Harrell, Lindy E.
Brockington, John C.
Clark, David G.
and
Marson, Daniel C.
2007.
Brain Proton MRS is Correlated with Financial Abilities in Patients with Alzheimer’s Disease.
Brain Imaging and Behavior,
Vol. 1,
Issue. 1-2,
p.
23.